RXDX - Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01 revenue of $0.65M beats by $0.18M
- Prometheus Biosciences press release ( NASDAQ: RXDX ): Q4 GAAP EPS of -$0.90 beats by $0.01 .
- Revenue of $0.65M (-37.5% Y/Y) beats by $0.18M .
For further details see:
Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01, revenue of $0.65M beats by $0.18M